O
Description
Biotech company founded in 2019 in London, developing orexin OX2R receptor agonists for narcolepsy type 1 and other neurological disorders with excessive daytime sleepiness. Founded by Medicxi in collaboration with Sosei Heptares. Merged into Centessa Pharmaceuticals in February 2021 and is now a Centessa subsidiary. Collaborated with Schrödinger for novel OX2R agonist discovery via GPCR structure-based drug design.